Thymalin.
About Thymalin
Thymalin is studied in tissue regeneration and repair research, including cell and animal models. Contains regulatory short peptides proposed to bind DNA/histone proteins and modulate gene expression; promotes T-lymphocyte differentiation and normalization of cytokine balance.
Research Application
Used and studied clinically for immune restoration following infections, surgery, and radiation exposure, and in age-related immune decline; a 2021 Russian study also examined it as adjunct therapy in elderly patients with severe COVID-19.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
- Khavinson VK, Morozov VG. Neuro Endocrinol Lett. 2003;24(3-4):233–240. PMID 14523363
- Kuznik B, et al. Adv Gerontol. 2021;11:368–376.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about Thymalin?
We reply personally – via email or Telegram.